These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Diagnostic and prognostic values of FDG-PET in patients with non-small cell lung cancer.
    Author: Abe K, Baba S, Kaneko K, Isoda T, Yabuuchi H, Sasaki M, Sakai S, Yoshino I, Honda H.
    Journal: Clin Imaging; 2009; 33(2):90-5. PubMed ID: 19237050.
    Abstract:
    PURPOSE: The aim of this study was to address the efficacy of 2-[F-18]-Fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in the staging of non-small cell lung cancer (NSCLC) and in prognostic prediction in patients with NSCLC. METHODS: Forty-four patients (26 males, 18 females) were analyzed. RESULTS: Accurate staging was obtained by addition of FDG-PET. Multivariate analysis indicated that the standardized uptake value of the primary tumor was the most significant prognostic factor for disease-free survival (P=.0073). CONCLUSION: FDG-PET is useful for the diagnosis of NSCLC and for prognostic prediction in patients with NSCLC.
    [Abstract] [Full Text] [Related] [New Search]